UNIVERSITY OF CALIFORNIA, DAVIS
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1905-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.ucdavis.edu
Monoclonal Antibody Therapy Plus Cyclosporine and Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Breast Cancer
Phase 1
- Conditions
- Breast Cancer
- First Posted Date
- 2004-06-17
- Last Posted Date
- 2013-08-07
- Lead Sponsor
- University of California, Davis
- Target Recruit Count
- 18
- Registration Number
- NCT00003920
- Locations
- 🇺🇸
University of California Davis Medical Center, Sacramento, California, United States
Monoclonal Antibody Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma
Phase 1
- Conditions
- Lymphoma
- First Posted Date
- 2003-06-02
- Last Posted Date
- 2013-08-07
- Lead Sponsor
- University of California, Davis
- Registration Number
- NCT00008021
- Locations
- 🇺🇸
University of California Davis Cancer Center, Sacramento, California, United States
Monoclonal Antibody Therapy, Paclitaxel, and Cyclosporine in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma
Phase 1
- Conditions
- Lymphoma
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-09-20
- Lead Sponsor
- University of California, Davis
- Registration Number
- NCT00009776
- Locations
- 🇺🇸
University of California Davis Cancer Center, Sacramento, California, United States
Monoclonal Antibody Therapy Plus Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
Phase 1
- Conditions
- Prostate Cancer
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-09-20
- Lead Sponsor
- University of California, Davis
- Registration Number
- NCT00009750
- Locations
- 🇺🇸
University of California Davis Cancer Center, Sacramento, California, United States
Monoclonal Antibody Therapy, Cyclosporine, and Paclitaxel in Treating Patients With Recurrent or Refractory Metastatic Breast Cancer
Phase 1
- Conditions
- Breast Cancer
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-09-20
- Lead Sponsor
- University of California, Davis
- Registration Number
- NCT00009763
- Locations
- 🇺🇸
University of California Davis Cancer Center, Sacramento, California, United States
© Copyright 2025. All Rights Reserved by MedPath